Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin FlexPro, is a recombinant human growth hormone presented as a 5 mg per pen solution for injection (pen) for subcutaneous use. It treats growth hormone deficiency and related growth disorders in children and adults.

GNH USA supplies Norditropin FlexPro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norditropin FlexPro (somatropin) is used to address conditions related to growth hormone deficiency and associated growth disorders.

- Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Turner syndrome: supports growth and increases final adult height. - Adult growth hormone deficiency: restores normal metabolic function and body composition. - Prader‑Willi syndrome: enhances growth and improves body composition. - Chronic renal insufficiency associated growth failure: aids in achieving normal growth patterns. - Idiopathic short stature: stimulates growth when other causes have been excluded.

Common Side Effects: - Injection site pain: mild discomfort at the injection site. - Headache: transient and usually mild. - Joint stiffness: occasional stiffness in large joints. - Swelling of extremities: peripheral edema, especially in hands and feet.

Serious or Rare Side Effects: - Intracranial hypertension: signs include headache, visual changes, and nausea. - Hyperglycemia: elevated blood glucose requiring monitoring. - Slipped capital femoral epiphysis: hip pain and limited motion in adolescents. - Severe allergic reaction (anaphylaxis): rash, difficulty breathing, or swelling of the face.

Before initiating therapy, consider the following precautions: - Monitor blood glucose: assess for hyperglycemia, especially in diabetic patients. - Assess for intracranial hypertension: watch for persistent headaches or visual disturbances. - Evaluate for musculoskeletal disorders: screen for scoliosis or hip joint abnormalities. - Screen for malignancy: avoid use in patients with active cancer. - Adjust dose in renal impairment: consider reduced dosing in severe renal insufficiency. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin may interact with several medicines. Review the following:

Major Interactions (Avoid): - Glucocorticoids: may antagonize growth hormone effects and reduce efficacy. - Estrogen therapy: can increase IGF‑1 levels, potentially leading to excess growth.

Moderate Interactions (Monitor Closely): - Oral hypoglycemic agents: may require adjustment of glucose‑lowering therapy. - Thyroid hormone replacement: monitor thyroid function tests regularly. - Diuretics: may affect fluid balance and exacerbate edema.